RESUMEN
BACKGROUND: Some epidemiologic studies have described positive associations between prostate cancer risk and meat consumption, but underlying mechanisms have not been identified. Heterocyclic amines are mutagens formed during the cooking of meat. Well-done meat has been associated with increased risks of colorectal and breast cancers in humans. This study examined associations between prostate cancer risk and 1) estimated daily intake of heterocyclic amines from cooked meat and 2) level of cooked-meat doneness. METHODS: A population-based, case-control study involving 317 case patients with prostate cancer and 480 age-matched control subjects was carried out in Auckland, New Zealand. Levels of meat doneness and daily intake of heterocyclic amines were determined from self-reported dietary data and experimentally measured heterocyclic amine levels in locally sourced meat samples cooked under controlled conditions to varying degrees of doneness. RESULTS: The heterocyclic amines found in the highest concentrations in meat samples were 2-amino-1,6-dimethylfuro[3,2-e]imidazo[4,5-b]pyridine (IFP) and 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) from well-done chicken and pork and very well-done beefsteak. Meat doneness was weakly and inconsistently associated with prostate cancer risk for individual types of meat, but increased risk was observed for well-done beefsteak (relative risk = 1.68; 95% confidence interval = 1.02-2.77; two-sided P for trend =.03). A weak positive gradient of increased risk was associated with estimated daily exposure to IFP but not with the other major heterocyclic amines. CONCLUSIONS: Meat doneness and estimated intake of heterocyclic amines from cooked meat were not clearly associated with prostate cancer risk.
Asunto(s)
Aminas/análisis , Culinaria , Carne , Mutágenos , Neoplasias de la Próstata/epidemiología , Adulto , Anciano , Estudios de Casos y Controles , Dieta , Humanos , Masculino , Carne/análisis , Persona de Mediana Edad , Mutágenos/análisis , Nueva Zelanda , Factores de RiesgoRESUMEN
A randomly selected group of 50 New Zealand wood workers was studied. The level of airborne wood dust to which they were exposed ranged from 1.0-24.5 mg/m3. The wood workers reported experiencing higher rates of both lower and upper respiratory tract symptoms than a control group of office workers. Inhaled wood dust, in particular from rimu (Dacrydium cupressinum), was frequently cited by workers as being associated with respiratory tract symptoms. The wood workers' responses to the respiratory symptom questionnaire, and serial recordings of peak expiratory flow rate were used to screen the group for suspected cases of occupational asthma. Five cases fulfilled the study's criteria for suspected occupational asthma. In four of these, further evidence was found to support this diagnosis. We conclude that exposure to wood dust may cause occupational asthma in the woodworking industry in New Zealand.
Asunto(s)
Asma/etiología , Polvo/efectos adversos , Enfermedades Profesionales/etiología , Madera , Adulto , Anciano , Asma/fisiopatología , Humanos , Masculino , Persona de Mediana Edad , Nueva Zelanda , Enfermedades Profesionales/fisiopatología , Exposición Profesional , Ápice del Flujo EspiratorioRESUMEN
The fatal and non-fatal injuries related to work in commercial fishermen operating out of New Zealand ports is described. Three data sources were used to provide information on the nature of the injuries sustained, as well as their circumstances. High rates of fatal and non-fatal injury were found, with most deaths attributed to drowning, and concerning a vessel operating in rough seas or poor weather. A higher fatal injury rate was found for the west coast of New Zealand when compared with the rest of the country. This is likely to be due to a combination of factors, including rougher sea conditions, a lower density of fishing vessels operating in the area, and the siting of many west coast fishing ports at dangerous river and harbour bars. Injuries to hands and fingers related to the use of winches, machinery and knives were common, as were back strains associated with lifting, and a variety of injuries resulting from falls. There is need for a comprehensive injury information source, such as an industry based register specific for fishing, so that effective preventative strategies and their evaluation can be developed.
Asunto(s)
Explotaciones Pesqueras , Enfermedades Profesionales/epidemiología , Heridas y Lesiones/epidemiología , Adolescente , Adulto , Anciano , Demografía , Ahogamiento/mortalidad , Humanos , Masculino , Persona de Mediana Edad , Nueva Zelanda/epidemiología , Enfermedades Profesionales/mortalidad , Tiempo (Meteorología) , Indemnización para Trabajadores , Heridas y Lesiones/economía , Heridas y Lesiones/mortalidadRESUMEN
Experimental studies have suggested that the biosynthesis of arachidonic acid-derived eicosanoids such as prostaglandin E2 via the cyclo-oxygenase pathway may play a significant role in supporting cell proliferation in human prostate cancer cell lines. However, the aetiological significance of this for clinical prostate cancer has remained unclear. In particular, the potential for prostate cancer chemoprevention using nonsteroidal anti-inflammatory drugs (cyclo-oxygenase inhibitors; NSAIDs) has received little attention. The purpose of our study was to investigate associations between prostate cancer risk and use of NSAIDs. A population-based case-control study was carried out over 13 months from 1996 in metropolitan Auckland, New Zealand. A total of 317 newly diagnosed prostate cancer cases (including 192 "advanced" cases) representative of all cancer cases in the study population were identified from urology clinic referrals and histology reports. A total of 480 age-matched controls were recruited following random selection from the study population using electoral rolls as the sampling frame. After adjusting for potential confounding by socio-economic status and dietary fat consumption, there was a trend toward reduced risks of advanced prostate cancer associated with regular use of total NSAIDs (RR = 0.73; 95% CI 0.50-1.07) and total aspirin (RR = 0.71; 95% CI 0.47-1.08). However, these associations failed to reach statistical significance at the usually accepted levels. Weaker inverse associations were found for total prostate cancers, which included a number of small, low-grade tumours of less clinical significance. These findings lend support to proposed underlying aetiological hypotheses which imply a role for cyclo-oxygenase activity in prostate cancer progression.
Asunto(s)
Antiinflamatorios no Esteroideos/administración & dosificación , Neoplasias de la Próstata/epidemiología , Adulto , Anciano , Anciano de 80 o más Años , Análisis de Varianza , Aspirina/administración & dosificación , Estudios de Casos y Controles , Grasas de la Dieta/administración & dosificación , Humanos , Masculino , Persona de Mediana Edad , Nueva Zelanda/epidemiología , Neoplasias de la Próstata/etiología , Medición de Riesgo , Factores SocioeconómicosRESUMEN
OBJECTIVES: To investigate (i) dietary patterns associated with consumption of vegetable oils rich in monounsaturated fatty acids (MUFA), and (ii) the risk of prostate cancer associated with consumption of these oils. METHODS: A population-based case-control study was conducted in Auckland, New Zealand, involving 317 prostate cancer cases and 480 controls. A food-frequency questionnaire was used to collect data concerning consumption of MUFA-rich vegetable oils (including olive oil, canola or peanut oil) and other dietary variables. Biomarkers for fatty acids were measured in erythrocytes. RESULTS: The group of participants who reported regular consumption of greater than 5.5 ml of MUFA-rich vegetable oils per day had a diet relatively high in monounsaturated fat, vegetables, lycopene, vitamin E, selenium, and n-3 fish oils. Increasing levels of MUFA-rich vegetable oil intake were associated with a progressive reduction in prostate cancer risk (multivariate relative risk = 0.5; 95% confidence interval 0.3-0.9; > 5.5 ml per day vs. nonconsumption, p trend = 0.005), and similar trends were observed across all strata of socioeconomic status. Prostate cancer risk was not associated with intake of total MUFA or the major animal food sources of MUFA. CONCLUSION: This finding may be explained by the protective effect of an associated dietary pattern high in antioxidants and fish oils, an independent protective effect of MUFA-rich vegetable oils unrelated to the MUFA component, or a combination of these factors.
Asunto(s)
Dieta , Ácidos Grasos Monoinsaturados/administración & dosificación , Aceites de Plantas/administración & dosificación , Neoplasias de la Próstata/prevención & control , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Casos y Controles , Eritrocitos/química , Ácidos Grasos/análisis , Humanos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Factores de Riesgo , Factores Socioeconómicos , Encuestas y CuestionariosRESUMEN
This population-based case-control study investigated associations between prostate cancer risk and dietary intake of the carotenoids beta-carotene and lycopene and their major plant food sources, including carrots, green leafy vegetables, and tomato-based foods. The study was carried out in Auckland, New Zealand, during 1996-1997 and recruited 317 prostate cancer cases and 480 controls. The authors found that dietary intake of beta-carotene and its main vegetable sources was largely unassociated with prostate cancer risk, whereas intake of lycopene and tomato-based foods was weakly associated with a reduced risk. These results suggest that in contrast to the findings regarding many types of cancers, vegetables rich in beta-carotene are not protective against prostate cancer. However, lycopene from tomato-based foods was found to be associated with a small reduction in risk.
Asunto(s)
Carotenoides/administración & dosificación , Dieta , Neoplasias de la Próstata/prevención & control , Verduras , Adulto , Anciano , Anciano de 80 o más Años , Sesgo , Estudios de Casos y Controles , Daucus carota , Encuestas sobre Dietas , Humanos , Modelos Logísticos , Solanum lycopersicum , Masculino , Persona de Mediana Edad , Nueva Zelanda/epidemiología , Vigilancia de la Población , Estudios Prospectivos , Neoplasias de la Próstata/epidemiología , Neoplasias de la Próstata/etiología , Factores de RiesgoRESUMEN
Previous studies have reported that adult height is positively associated with the risk of prostate cancer. The authors carried out a population-based case-control study involving 317 prostate cancer cases and 480 controls to further investigate the possibility that height is more strongly associated with advanced, compared with localized forms of this disease. Since the inherited endocrine factors, which in part determine height attained during the growing years, may influence the risk of familial prostate cancer later in life, the relationship with height was also investigated for familial versus sporadic prostate cancers. Adult height was not related to the risk of localized prostate cancer, but there was a moderate positive association between increasing height and the risk of advanced cancer (relative risk (RR) = 1.62; 95% confidence interval (CI) 0.97-2.73, upper versus lowest quartile, P-trend = 0.07). Height was more strongly associated with the risk of prostate cancer in men with a positive family history compared with those reporting a negative family history. The RR of advanced prostate cancer for men in the upper height quartile with a positive family history was 7.41 (95% CI 1.68-32.67, P-trend = 0.02) compared with a reference group comprised of men in the shortest height quartile with a negative family history. Serum insulin-like growth factor-1 levels did not correlate with height amongst men with familial or sporadic prostate cancers. These findings provide evidence for the existence of growth-related risk factors for prostate cancer, particularly for advanced and familial forms of this disease. The possible existence of inherited mechanisms affecting both somatic and tumour growth deserves further investigation.
Asunto(s)
Estatura , Neoplasias de la Próstata/etiología , Adulto , Anciano , Anciano de 80 o más Años , Biomarcadores de Tumor/sangre , Intervalos de Confianza , Familia , Humanos , Factor I del Crecimiento Similar a la Insulina/análisis , Masculino , Persona de Mediana Edad , Análisis Multivariante , Neoplasias de la Próstata/sangre , Neoplasias de la Próstata/patología , Factores de Riesgo , Factores SocioeconómicosRESUMEN
OBJECTIVES: To compare traditional prognostic characteristics of familial vs sporadic prostate cancers and to investigate potential detection biases arising from differences in the use of screening and investigative procedures. PATIENTS AND METHODS: Familial and sporadic cancers were identified in a population-based sample of incident prostate cancers (total 318) in Auckland, New Zealand. To examine the potential for detection biases in these comparisons, the sociodemographic and clinical characteristics were determined according to family history status for a sample of 959 patients newly referred to Auckland urology clinics by general practitioners for the investigation of prostate-related conditions. RESULTS: Compared with sporadic prostate cancers, familial cancers were more likely to be diagnosed in patients at a younger age (P=0.05), after asymptomatic serum prostate-specific antigen (PSA) screening (P=0. 02), and to include a lower proportion with extraprostatic disease (P=0.009) and serum PSA levels before diagnosis of >20 ng/mL (P=0. 04). This was consistent with the observed trend for patients referred to urology clinics with a positive family history to be of higher socio-economic and educational status and to more frequently undergo screening and biopsy investigation. CONCLUSION: Familial prostate cancers appeared to be diagnosed at an earlier stage of disease progression in this study population, possibly as the result of the higher socio-economic status and greater use of screening and investigative procedures amongst patients reporting a positive family history. These features reduce the validity of cross-sectional comparisons of prognostic variables for familial vs sporadic prostate cancer and emphasize the need for further longitudinal prognostic studies.
Asunto(s)
Neoplasias de la Próstata/genética , Adulto , Edad de Inicio , Anciano , Anciano de 80 o más Años , Humanos , Masculino , Persona de Mediana Edad , Nueva Zelanda/epidemiología , Linaje , Prevalencia , Pronóstico , Estudios Prospectivos , Neoplasias de la Próstata/epidemiología , Neoplasias de la Próstata/patología , Factores Socioeconómicos , Salud UrbanaRESUMEN
Experimental studies suggest that the risk of prostate cancer is reduced with the intake of long-chain n-3 polyunsaturated fatty acids derived from marine foods, such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). However, few human studies have been conducted due to difficulties in assessing the dietary intake of these fatty acids. The authors examined the relationship between prostate cancer risk and EPA and DHA in erythrocyte biomarkers in a population-based case-control study in Auckland, New Zealand during 1996-1997 involving 317 prostate cancer cases and 480 age-matched community controls. Reduced prostate cancer risk was associated with high erythrocyte phosphatidylcholine levels of EPA (multivariate relative risk = 0.59; 95% confidence interval 0.37-0.95, upper vs lowest quartile) and DHA (multivariate relative risk = 0.62; 95% confidence interval 0.39-0.98, upper vs lowest quartile). These analyses support evidence from in vitro experiments for a reduced risk of prostate cancer associated with dietary fish oils, possibly acting via inhibition of arachidonic acid-derived eicosanoid biosynthesis.